The prognostic role of nephrectomy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with immunotherapy according to the novel prognostic Meet-URO score: Subanalysis of the Meet-URO 15 study.

被引：0
|
作者：
Rebuzzi, Sara Elena
Signori, Alessio
Banna, Giuseppe Luigi L.
Buti, Sebastiano
Rescigno, Pasquale
Gemelli, Maria
Panni, Stefano
Massari, Francesco
Soraru, Mariella
Santoni, Matteo
Cortellini, Alessio
Prati, Veronica
Parra, Hector Jose Soto
Atzori, Francesco
Di Napoli, Marilena
Caffo, Orazio
Messina, Marco
Morelli, Franco
Prati, Giuseppe
Fornarini, Giuseppe
机构：
[1] Univ Genoa, Meet URO Italian Network Res Urol Oncol, Genoa, Italy
[2] Univ Genoa, Dept Internal Med & Med Specialties DiMI, Genoa, Italy
[3] Osped San Paolo, Med Oncol Unit, Savona, Italy
[4] Univ Genoa, Sect Biostat, Dept Hlth Sci DISSAL, Genoa, Italy
[5] FPO IRCCS, Candiolo Canc Inst, Candiolo, Italy
[6] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[7] Univ Parma, Dept Med & Surg, Parma, Italy
[8] IRCCS MultiMed, Med Oncol Unit, Milan, Italy
[9] ASST Ist Ospitalieri Cremona Hosp, Med Oncol Unit, Cremona, Italy
[10] IRCCS Azienda Osped Univ Bologna, Med Oncol, Bologna, Italy
[11] Camposampiero Hosp, Med Oncol, Camposampiero, Italy
[12] Macerata Gen Hosp, Med Oncol Unit, Macerata, Italy
[13] Imperial Coll London, Hammersmith Hosp, Fac Med, Dept Surg & Canc, London, England
[14] Univ LAquila, Dept Biotechnol & Appl Clin Sci, London, England
[15] Osped S Lazzaro Azienda Sanit Locale CN2, Dept Med Oncol, Alba Bra, Cuneo, Italy
[16] Univ Hosp Policlin San Marco, Med Oncol, Dept Oncol, Catania, Italy
[17] Univ Cagliari, Univ Hosp, Dept Med Oncol, Cagliari, Italy
[18] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Urol & Gynecol, Naples, Italy
[19] APSS Trento, Presidio Osped Santa Chiara Trento, Trento, Italy
[20] ARNAS Civ, Med Oncol Unit, Palermo, Italy
[21] IRCCS Casa Sollievo Sofferenza, Dept Med Oncol, San Giovanni Rotondo, Italy
[22] Azienda USL IRCCS Reggio Emilia, Dept Oncol & Adv Technol, Oncol Unit, Reggio Emilia, Italy
[23] IRCCS Osped Policlin San Martino, Med Oncol Unit 1, Genoa, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4535
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic stratification by the Meet-URO score in a real-world elderly population of patients (pts) with metastatic renal cell carcinoma (mRCC) receiving cabozantinib: A subanalysis of the prospective ZEBRA study (Meet-URO 9).
    Damassi, Alessandra
    Cremante, Malvina
    Fornarini, Giuseppe
    Signori, Alessio
    Buti, Sebastiano
    Basso, Umberto
    Procopio, Giuseppe
    Maruzzo, Marco
    Soraru, Mariella
    Di Napoli, Marilena
    Fratino, Lucia
    Santini, Daniele
    Grillone, Francesco
    Ballestrin, Melissa
    Dionese, Michele
    Murianni, Veronica
    Catalano, Fabio
    Banna, Giuseppe Luigi L.
    Rescigno, Pasquale
    Rebuzzi, Sara Elena
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9)
    Damassi, Alessandra
    Cremante, Malvina
    Signori, Alessio
    Rebuzzi, Sara Elena
    Fornarini, Giuseppe
    Giudice, Giulia Claire
    Maruzzo, Marco
    Procopio, Giuseppe
    Soraru, Mariella
    Di Napoli, Marilena
    Fratino, Lucia
    Santini, Daniele
    Grillone, Francesco
    Ballestrin, Melissa
    Dionese, Michele
    Nasso, Cecilia
    Catalano, Fabio
    Murianni, Veronica
    Rescigno, Pasquale
    Anpalakhan, Shobana
    Banna, Giuseppe Luigi
    Basso, Umberto
    Buti, Sebastiano
    [J]. CLINICAL GENITOURINARY CANCER, 2024, 22 (02)
  • [3] Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)
    Rebuzzi, Sara Elena
    Signori, Alessio
    Banna, Giuseppe Luigi
    Maruzzo, Marco
    De Giorgi, Ugo
    Pedrazzoli, Paolo
    Sbrana, Andrea
    Zucali, Paolo Andrea
    Masini, Cristina
    Naglieri, Emanuele
    Procopio, Giuseppe
    Merler, Sara
    Tomasello, Laura
    Fratino, Lucia
    Baldessari, Cinzia
    Ricotta, Riccardo
    Panni, Stefano
    Mollica, Veronica
    Soraru, Maria
    Santoni, Matteo
    Cortellini, Alessio
    Prati, Veronica
    Soto Parra, Hector Jose
    Stellato, Marco
    Atzori, Francesco
    Pignata, Sandro
    Messina, Carlo
    Messina, Marco
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Vignani, Francesca
    Cavo, Alessia
    Roviello, Giandomenico
    Pierantoni, Francesco
    Casadei, Chiara
    Bersanelli, Melissa
    Chiellino, Silvia
    Paolieri, Federico
    Perrino, Matteo
    Brunelli, Matteo
    Iacovelli, Roberto
    Porta, Camillo
    Buti, Sebastiano
    Fornarini, Giuseppe
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [4] The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study
    Rebuzzi, Sara Elena
    Signori, Alessio
    Banna, Giuseppe Luigi
    Gandini, Annalice
    Fornarini, Giuseppe
    Damassi, Alessandra
    Maruzzo, Marco
    De Giorgi, Ugo
    Basso, Umberto
    Chiellino, Silvia
    Galli, Luca
    Zucali, Paolo Andrea
    Fantinel, Emanuela
    Naglieri, Emanuele
    Procopio, Giuseppe
    Milella, Michele
    Boccardo, Francesco
    Fratino, Lucia
    Pipitone, Stefania
    Ricotta, Riccardo
    Panni, Stefano
    Mollica, Veronica
    Soraru, Mariella
    Santoni, Matteo
    Cortellini, Alessio
    Prati, Veronica
    Soto Parra, Hector Jose
    Santini, Daniele
    Atzori, Francesco
    Di Napoli, Marilena
    Caffo, Orazio
    Messina, Marco
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Vignani, Francesca
    Cavo, Alessia
    Roviello, Giandomenico
    Rescigno, Pasquale
    Buti, Sebastiano
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [5] The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study
    Sara Elena Rebuzzi
    Alessio Signori
    Giuseppe Luigi Banna
    Annalice Gandini
    Giuseppe Fornarini
    Alessandra Damassi
    Marco Maruzzo
    Ugo De Giorgi
    Umberto Basso
    Silvia Chiellino
    Luca Galli
    Paolo Andrea Zucali
    Emanuela Fantinel
    Emanuele Naglieri
    Giuseppe Procopio
    Michele Milella
    Francesco Boccardo
    Lucia Fratino
    Stefania Pipitone
    Riccardo Ricotta
    Stefano Panni
    Veronica Mollica
    Mariella Sorarù
    Matteo Santoni
    Alessio Cortellini
    Veronica Prati
    Hector Josè Soto Parra
    Daniele Santini
    Francesco Atzori
    Marilena Di Napoli
    Orazio Caffo
    Marco Messina
    Franco Morelli
    Giuseppe Prati
    Franco Nolè
    Francesca Vignani
    Alessia Cavo
    Giandomenico Roviello
    Pasquale Rescigno
    Sebastiano Buti
    [J]. Journal of Translational Medicine, 20
  • [6] The prognostic value of peripheral blood inflammatory indices early variation in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with nivolumab (Δ-Meet-URO analysis).
    Rebuzzi, Sara Elena
    Signori, Alessio
    Buti, Sebastiano
    Banna, Giuseppe Luigi L.
    Stellato, Marco
    Santini, Daniele
    Basso, Umberto
    De Giorgi, Ugo
    Chiellino, Silvia
    Salfi, Alessia
    Zucali, Paolo Andrea
    Masini, Cristina
    Naglieri, Emanuele
    Procopio, Giuseppe
    Milella, Michele
    Boccardo, Francesco
    Fratino, Lucia
    Pipitone, Stefania
    Porta, Camillo
    Fornarini, Giuseppe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study) (vol 13, pg 1, 2021)
    Rebuzzi, S. E.
    Signori, A.
    Banna, G.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [8] Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
    Rebuzzi, Sara Elena
    Cerbone, Luigi
    Signori, Alessio
    Santoni, Matteo
    Murianni, Veronica
    De Giorgi, Ugo
    Procopio, Giuseppe
    Porta, Camillo
    Milella, Michele
    Basso, Umberto
    Massari, Francesco
    Maruzzo, Marco
    Iacovelli, Roberto
    Battelli, Nicola
    Carmisciano, Luca
    Banna, Giuseppe Luigi
    Buti, Sebastiano
    Fornarini, Giuseppe
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [9] Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study
    Catalano, Martina
    Rebuzzi, Sara Elena
    Maruzzo, Marco
    De Giorgi, Ugo
    Buti, Sebastiano
    Galli, Luca
    Fornarini, Giuseppe
    Zucali, Paolo Andrea
    Claps, Melanie
    Chiellino, Silvia
    Zampiva, Ilaria
    Pipitone, Stefania
    Ricotta, Riccardo
    Soraru, Mariella
    Mollica, Veronica
    Tudini, Marianna
    Fratino, Lucia
    Prati, Veronica
    Caffo, Orazio
    Atzori, Francesco
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Vignani, Francesca
    Cavo, Alessia
    Di Napoli, Marilena
    Malgeri, Andrea
    Naglieri, Emanuele
    Signori, Alessio
    Banna, Giuseppe Luigi
    Rescigno, Pasquale
    Cerbone, Linda
    Antonuzzo, Lorenzo
    Roviello, Giandomenico
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
    Bersanelli, Melissa
    Buti, Sebastiano
    Cortellini, Alessio
    Bandini, Marco
    Banna, Giuseppe Luigi
    Pederzoli, Filippo
    Fare, Elena
    Raggi, Daniele
    Giannatempo, Patrizia
    De Giorgi, Ugo
    Basso, Umberto
    Losanno, Tania
    Santini, Daniele
    Mucciarini, Claudia
    Tucci, Marcello
    Tambaro, Rosa
    Farnesi, Azzurra
    Caffo, Orazio
    Veccia, Antonello
    Naglieri, Emanuele
    Briganti, Alberto
    Procopio, Giuseppe
    Pignata, Sandro
    Necchi, Andrea
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
12345